Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

Adoptive transfer of tumor-infiltrating lymphocytes (TIL) has shown promising yet sometimes suboptimal results in clinical trials for advanced cancer, underscoring the need for approaches improving efficacy and safety. Six implantable syngeneic tumor cell lines of the Syrian hamster were used to ini...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Siurala, Mikko, Vähä-Koskela, Markus, Havunen, Riikka, Tähtinen, Siri, Bramante, Simona, Parviainen, Suvi, Mathis, J. Michael, Kanerva, Anna, Hemminki, Akseli
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910707/
https://ncbi.nlm.nih.gov/pubmed/27467954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1136046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars